KZR Stock Analysis: Buy, Sell, or Hold?
KZR - Kezar Life Sciences, Inc. Common Stock
$7.29
-0.07 (-0.95%)
âŧ
5d:
-0.55%
30d:
-0.82%
90d:
+19.12%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When KZR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: KZR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: KZR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: KZR is currently trading at $7.29, which is considered fair based on recent price action.
Technical Outlook: Technically, KZR is in a strong uptrend. The price is currently testing key support at $7.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $6.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KZR is in a strong uptrend. The price is currently testing key support at $7.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $6.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
47/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
58.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Trading 17.7% above Wall St target ($6.00)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$7.23
Resistance Level
$7.45
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.84
Wall Street Target
$6.00
(-17.7%)
Share & Embed Analysis
Last updated: August 23, 2026 4:47 PM ET
Data refreshes hourly during market hours. Next update: 5:47 PM
Data refreshes hourly during market hours. Next update: 5:47 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KZR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
